CSIMarket
 

Cue Health Inc   (NASDAQ: HLTH)

Cue Health Inc 's

Competitiveness




 

HLTH Sales vs. its Competitors Q4 2023



Comparing the current results to its competitors, Cue Health Inc reported Revenue decrease in the 4 quarter 2023 year on year by -87.19 %, despite the revenue increase by the most of its competitors of 0.88 %, recorded in the same quarter.

List of HLTH Competitors





Revenue Growth Comparisons




Net Income Comparison


Cue Health Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 34.42 %

<<  HLTH Stock Performance Comparisons


Cue Health Inc 's Comment on Competition and Industry Peers


The diagnostic testing industry is highly competitive and evolving rapidly. The company faces competition from entities developing molecular tests for at-home, over-the-counter, and point-of-care use, as well as antigen and antibody tests. Competitors include public and private companies, academic and research institutions, and governmental agencies. Notable competitors with diagnostic testing platforms include 1Life Healthcare, Inc. (d/b/a OneMedical), American Well, Inc., Hims & Hers Health, Inc., and Teladoc Health, Inc. These competitors often possess greater financial resources and more experience in research and development, manufacturing, clinical development, regulatory approvals, and marketing. Smaller or early-stage companies may also present competition, either independently or through strategic partnerships. Competition also exists in recruiting and retaining qualified personnel and establishing clinical trial sites.



  

Overall company Market Share Q4 2023

Overall company, revenue fell by -87.19 % and company lost market share, to approximately 0.01 %.




<<  More on HLTH Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Cue Health Inc




Accelerate Diagnostics Inc
Share Performance



-97.30%
This Year



Accelerate Diagnostics Inc
Profile

Accelerate Diagnostics Inc operates under a business model that focuses on developing and commercializing innovative solutions for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. Their products offer healthcare facilities a more efficient and accurate approach to diagnosing and treating infections, ultimately improving patient outcomes.

More about Accelerate Diagnostics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.792 mill. $ 11.071 mill. $ -50.045 mill.


Hims and Hers Health Inc
Share Performance



-31.52%
One Year



Hims and Hers Health Inc
Profile

Hims and Hers Health Inc's business model is centered around providing direct-to-consumer telehealth services for a wide range of health and wellness needs.

More about Hims and Hers Health Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6,590.860 mill. $ 2,578.494 mill. $ -142.030 mill.


Hologic Inc
Share Performance



+1.46%
This Year



Hologic Inc
Profile

Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.

More about Hologic Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 17,087.746 mill. $ 3,644.800 mill. $ 543.800 mill.


Kroger Co
Share Performance



-0.48%
30 Days



Kroger Co
Profile

The Kroger Co operates a multi-channel retail business model centered on grocery and household essentials, providing a diverse selection of products ranging from food to pharmacy items through physical stores, e-commerce platforms, and delivery services. The company emphasizes customer value and convenience while leveraging operational efficiencies and strong supplier partnerships to offer competitive pricing.

More about Kroger Co 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 37,950.700 mill. $ 146,551.000 mill. $ 780.000 mill.


Labcorp Holdings Inc
Share Performance



-2.98%
Over The Past 5 Days



Labcorp Holdings Inc
Profile

Labcorp Holdings Inc operates as a major healthcare diagnostics company, providing clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model emphasizes delivering accurate and timely test results to aid in patient diagnosis, treatment, and monitoring.

More about Labcorp Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 27,158.869 mill. $ 14,144.200 mill. $ 942.700 mill.

13 more competitors available

Sign in to see all competitors

Sources: Cue Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cue Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.